Clinical Trial Update: Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome [Phase 4]

View source ↗

Summary

Phase 4 study assessing whether genetic screening for HLA-B*1301 can predict susceptibility to dapsone hypersensitivity syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne
• Allergic Cutaneous Vasculitis
• Bullous Skin Diseases
• Leprosy
• Pneumocystis Pneumonia
• Psoriasis
• Sterile Pustulosis
• Urticaria

Drugs mentioned

• DAPSONE (dapsone)

Snippet

Sponsor: Shandong Provincial Institute of Dermatology and Venereology | Conditions: Allergic Cutaneous Vasculitis, Urticaria | Phase 4 | Status: UNKNOWN